![]()
|
|
|
Stepping up to the platform
August 2012
SHARING OPTIONS:
TAINAN, Taiwan—National Cheng Kung University (NCKU) of
southern Taiwan and Fujitsu Taiwan Ltd. recently announced the signing of a
memorandum of understanding (MOU) to build a comprehensive genomics research
platform. The platform will consist of genomics and bioinformatics research,
and the parties seek to jointly promote computational biology, develop
personnel training for bioinformatics and also develop biology analysis
software.
Dr. Hwung-Hweng Hwung, president of NCKU, called the
partnership one based on shared benefits and strong collaborations. Hwung and
Ikegami Ichirou, the general manager of Fujitsu Taiwan, signed the MOU for
their respective institutions.
“NCKU’s research on genomics and the original species of
Taiwan has shown great achievement and its extensive relations with
world-renowned scientific institutes are fruitful in collaborated results,”
said Ikegami in a press release, noting that NCKU is home to distinguished
researchers and represents the first university in Taiwan that Fujitsu has
looked forward to working with.
Chi-Chuan Hwang, chair professor of NCKU Engineering
Science, said in a press release that the initial focus will be on developing
talents, and then collecting data on original species found in Taiwan and
training personnel to work with biology data analysis. NCKU brings with it
experience in engineering research while Fujitsu offers its input as a leading
Japanese information and communication technology company. The resulting
platform will explore important genomics research issues, and is expected to
increase NCKU’s participation in global genetics research. NCKU and Fujitsu
will share research and development results.
Both organizations have been active in establishing and
furthering new partnerships. Fujitsu Ireland announced earlier this month that
Fujitsu Laboratories Ltd. was beginning a significant investment in a research
program with Digital Enterprise Research Institute based in NUI Galway, a
program that will focus research in networked knowledge. In late June, Fujitsu
Ltd., Fujitsu Laboratories Ltd. and Nagoya University announced that they had
begun joint research on the collection and visualization of health information,
utilizing a wristwatch-style monitoring device and system developed by Fujitsu
Laboratories.
In mid-May, NCKU announced that one of its research teams,
led by Ming-Shi Chang, an NCKU professor in the Department of Biochemistry and
Molecular Biology, had discovered an anti-interleukin-20 antibody. The antibody
represents a potential new anti-osteoporosis and anti-rheumatoid arthritis
drug, and NCKU agreed to license select intellectual property and transfer
appropriate technology to Novo Nordisk AS for $13.3 million if the project is
successfully completed. Prof. Chang and Novo Nordisk also established a
two-year research collaboration that would seek to strengthen, and if possible,
expand the potential uses of the anti-interleukin-20 antibody. The discovery
was published in the Journal of Experimental Medicine.
NCKU also held a seminar in May regarding one of its
longer-running industry-academic collaborations with Delta Electronics. The
partnership has entered its fourth year, and over that span of time, a total of
60 collaborative projects have been published. So far in 2012, the NCKU-Delta
Electronic Joint Research Center has a total funding of approximately 20
million, and with that has approved 14 research projects.
The university’s latest partnership consists of the signing
of three MOUs with AECOM, a U.S.-based technical services company, that focus
on environmental protection and city development by way of scientific and
technical interaction, water research and natural disaster assessment. Code: E081211 Back |
|
||
|
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|